These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6816948)

  • 1. Gonadal influences on the inhibition of monoamine oxidase type B activity.
    Vaccari A; Biassoni R
    J Neurosci Res; 1982; 8(1):13-9. PubMed ID: 6816948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothalamic monoamine oxidase activity in ovariectomized rats after sexual behavior restoration.
    Ortega-Corona BG; Valencia-Sánchez A; Kubli-Garfias C; Anton-Tay F; Salazar LA; Villarreal JE; Ponce-Monter H
    Arch Med Res; 1994; 25(3):337-40. PubMed ID: 7803985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recovery of MAO-B enzyme activity after (-)deprenyl (selegiline) pretreatment, measured in vivo.
    Timár J
    Acta Physiol Hung; 1989; 74(3-4):259-66. PubMed ID: 2517980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The functional consequences of inhibition of monoamine oxidase type B: comparison of the pharmacological properties of L-deprenyl and MDL 72145.
    Fozard JR; Zreika M; Robin M; Palfreyman MG
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):186-93. PubMed ID: 3937059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadal influences on the sexual differentiation of monoamine oxidase type A and B activities in the rat brain.
    Vaccari A; Caviglia A; Sparatore A; Biassoni R
    J Neurochem; 1981 Sep; 37(3):640-8. PubMed ID: 7276946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of monoamine oxidase type A, but not type B, is an effective means of inducing anticonvulsant activity in the kindling model of epilepsy.
    Löscher W; Lehmann H; Teschendorf HJ; Traut M; Gross G
    J Pharmacol Exp Ther; 1999 Mar; 288(3):984-92. PubMed ID: 10027835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperserotonergic phenotype after monoamine oxidase inhibition in larval zebrafish.
    Sallinen V; Sundvik M; Reenilä I; Peitsaro N; Khrustalyov D; Anichtchik O; Toleikyte G; Kaslin J; Panula P
    J Neurochem; 2009 Apr; 109(2):403-15. PubMed ID: 19222706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different sensitivity of mitochondrial and cytosolic monoamine oxidases to in vivo but not in vitro inhibition by specific irreversible inhibitors.
    Moskvitina TA; Medvedev AE
    Med Sci Monit; 2001; 7(1):17-9. PubMed ID: 11208486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. R-(-)-Deprenyl inhibits monocytic THP-1 cell neurotoxicity independently of monoamine oxidase inhibition.
    Klegeris A; McGeer PL
    Exp Neurol; 2000 Dec; 166(2):458-64. PubMed ID: 11085911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput screening for monoamine oxidase-A and monoamine oxidase-B inhibitors using one-step fluorescence assay.
    Guang HM; Du GH
    Acta Pharmacol Sin; 2006 Jun; 27(6):760-6. PubMed ID: 16723097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychomotor stimulant effects of beta-phenylethylamine in monkeys treated with MAO-B inhibitors.
    Bergman J; Yasar S; Winger G
    Psychopharmacology (Berl); 2001 Dec; 159(1):21-30. PubMed ID: 11797065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
    Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
    Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [History of deprenyl--the first selective inhibitor of monoamine oxidase type B].
    Knoll J
    Vopr Med Khim; 1997; 43(6):482-93. PubMed ID: 9503565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (-)-Deprenyl, a selective MAO-B inhibitor, with apoptotic and anti-apoptotic properties.
    Magyar K; Szende B
    Neurotoxicology; 2004 Jan; 25(1-2):233-42. PubMed ID: 14697898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Species-dependent differences in monoamine oxidase A and B-catalyzed oxidation of various C4 substituted 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridinyl derivatives.
    Inoue H; Castagnoli K; Van Der Schyf C; Mabic S; Igarashi K; Castagnoli N
    J Pharmacol Exp Ther; 1999 Nov; 291(2):856-64. PubMed ID: 10525109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive aspects of congenital learned helplessness and its reversal by the monoamine oxidase (MAO)-B inhibitor deprenyl.
    Schulz D; Mirrione MM; Henn FA
    Neurobiol Learn Mem; 2010 Feb; 93(2):291-301. PubMed ID: 19931627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of a new antiparkinsonian drug himantane on monoamine oxidase activity].
    Val'dman EA; Voronina TA; Aksenova LN; Buneeva OA; Medvedev AE
    Eksp Klin Farmakol; 2003; 66(5):3-5. PubMed ID: 14650204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of MAO-A activity enhances behavioural activity of rats assessed using water maze and open arena tasks.
    Barbelivien A; Nyman L; Haapalinna A; Sirviö J
    Pharmacol Toxicol; 2001 Jun; 88(6):304-12. PubMed ID: 11453370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoamine oxidase A rather than monoamine oxidase B inhibition increases nicotine reinforcement in rats.
    Guillem K; Vouillac C; Azar MR; Parsons LH; Koob GF; Cador M; Stinus L
    Eur J Neurosci; 2006 Dec; 24(12):3532-40. PubMed ID: 17229101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulations of brain amines and dopaminergic behavior by a novel, reversible and selective MAO-B inhibitor.
    Mishra N; Sasmal D
    Brain Res; 2012 Aug; 1470():45-51. PubMed ID: 22765918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.